Publications by authors named "Malte Ritter"

Claim this Profile
E
Ex Vivo Evaluation of Poly(Solketal Acrylate) Nanoparticles for Intravitreal Drug Delivery to the Posterior Eye Segment.
Yasaman Pourdakheli Hamedani, José Hurst, Malte Ritter, Philipp Weingarten, Julia Skokowa

Macromol Rapid Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuning of G-CSFR signaling by de novo-designed agonists.
Timo Ullrich, Christoph Pollmann, Malte Ritter, Jérémy Haaf, Narges Aghaallaei

Mol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-guide RNA Cas9 and enhanced-deletion Cas9 rescue a recurrent -related splicing defect.
Pietro De Angeli, Salome Spaag, Stefanida Shliaga, Arturo Flores-Tufiño, Malte Ritter

Mol Ther Nucleic Acids· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new severe congenital neutropenia syndrome associated with autosomal recessive COPZ1 mutations.
Natalia Borbaran Bravo, Ekaterina Deordieva, Larissa Doll, Mohammad ElGamacy, Benjamin Dannenmann, Malte Ritter

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the genetic landscape of congenital neutropenia: mutations in three families revealed through whole exome sequencing.
Maksim Klimiankou, Ivan Tesakov, Grigorios Tsaknakis, Erasmia Boutakoglou, Irene Mavroudi, Malte Ritter

Haematologica· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Gene-Editing Approaches for Severe Congenital Neutropenia-Causing Mutations in the Gene.
Malte Ulrich Ritter, Masoud Nasri, Benjamin Dannenmann, Perihan Mir, Benjamin Secker

CRISPR J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Masoud Nasri, Malte U Ritter, Perihan Mir, Benjamin Dannenmann, Masako M Kaufmann

Mol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring mutations.
Alexander Zeidler, Natalia Borbaran-Bravo, Benjamin Dannenmann, Malte Ritter, Masoud Nasri

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients.
Dominik Sonanini, Johannes Schwenck, Simone Blaess, Julia Schmitt, Andreas Maurer, Malte Ritter

Biomark Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
Benjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald, Anna Solovyeva, Jehan Mardan, Malte Ritter

Cell Stem Cell· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regenerative medicine meets translational oncology: Modeling leukemic bone marrow niche.
Natalia Borbaran-Bravo, Patricia Arreba-Tutusaus, Malte U Ritter, Masoud Nasri, Maksim Klimiankou

Cell Rep Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A topological refactoring design strategy yields highly stable granulopoietic proteins.
Julia Skokowa, Birte Hernandez Alvarez, Murray Coles, Malte Ritter, Masoud Nasri

Nat Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
Benjamin Dannenmann, Maksim Klimiankou, Benedikt Oswald, Anna Solovyeva, Jehan Mardan, Malte Ritter

Cell Stem Cell· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Knockout in Hematopoietic Stem and Progenitor Cells Followed by Granulocytic Differentiation.
Perihan Mir, Malte Ritter, Karl Welte, Julia Skokowa, Maksim Klimiankou

Methods Mol Biol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperating, congenital neutropenia-associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCs.
Malte Ritter, Maksim Klimiankou, Olga Klimenkova, Axel Schambach, Dirk Hoffmann

Ann Hematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9-mediated knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients.
Masoud Nasri, Malte Ritter, Perihan Mir, Benjamin Dannenmann, Narges Aghaallaei

Haematologica· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.
Tatsuya Morishima, Ann-Christin Krahl, Masoud Nasri, Yun Xu, Narges Aghaallaei, Malte Ritter

Blood· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac and electrophysiological effects of primary and refined extracts from Leonurus cardiaca L. (Ph.Eur.).
Malte Ritter, Kerstin Melichar, Sabine Strahler, Kenny Kuchta, Jan Schulte

Planta Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis